Tags : In-Silico

Merck Licenses Cyclica’s In-Silico Artificial Intelligence (AI) based Ligand Express

Shots: Merck to get rights for Cyclica’s cloud-based in-silico proteome screening AI platform, Ligand Express to screen small molecule for determining polypharmacological profiles The focus of agreement is to discover and develop clinical candidates using AI and computational biophysics Ligand Express Platform is an AI based platform, used for understanding drug’s effect with captured panoramic […]Read More